Brianada Koentjoro
Royal North Shore Hospital And University Of Sydney, St. Leonards
North Shore, NSW, Australia
North Shore, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Single Heterozygous ATP13A2 Mutations Cause Cellular Dysfunction Associated with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 03, 2017
Commentary: Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Journal: Frontiers in molecular neuroscience
Published: May 25, 2017
Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Journal: Scientific reports
Published: September 21, 2016
Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models.
Journal: Parkinsonism & related disorders
Published: October 27, 2015
The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.
Journal: Human molecular genetics
Published: May 24, 2014
Parkin western blotting is useful for identification of patients with Parkin-related Parkinson's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 13, 2014
Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
Journal: Human molecular genetics
Published: January 09, 2014
Phenotypic variability of parkin mutations in single kindred.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 22, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026